Challenges of Microarray Data and the Evaluation of Gene Expression Profile Signatures

REFERENCES

• Simon R. M., Korn E. L., McShane L. M., Radmacher M. D., Wright G. W., Zhao Y. Design and Analysis of DNA Microarray Investigations. Springer, New York 2003
   Google Scholar
• Korn E. L., McShane L. M., Troendle I. F., Rosenwald A., Simon R. Identifying pre-post chemotherapy differences in gene expression in breast tumors: a statistical method appropriate for this aim. Br J Cancer 2002; 86: 1093–1096
   PubMed Web of Science ®Google Scholar
• Yang S. X., Simon R. M., Tan A. R., Nguyen D., Swain S. M. Gene expression patterns and profile changes pre- and post-Erlotinib treatment in patients with metastatic breast cancer. Clin Cancer Res 2005; 11: 6226–6232
   PubMedGoogle Scholar
• Sotiriou C., Neo S. Y., McShane L. M., et al. Breast cancer classification and prognosis based on gene expression profiles from a population based study. Proc Natl Acad Sci USA 2003; 100(18)10393–10398
   PubMed Web of Science ®Google Scholar
• Desai K. V., Xiao N., Wang W., et al. Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proc Natl Acad Sci USA 2002; 99: 6967–6972
   PubMed Web of Science ®Google Scholar
• Simon R. Diagnostic and prognostic prediction using gene expression profiles in high dimensional microarray data. Br J Cancer 2003; 89: 1599–1604
   PubMed Web of Science ®Google Scholar
• Simon R. Development and validation of therapeutically relevant multi-gene biomarker classifiers. J Natl Cancer Inst 2005; 97: 866–867
   PubMed Web of Science ®Google Scholar
• van't Veer L. J., Dai H., Vijver MJvd., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530–536
   PubMed Web of Science ®Google Scholar
• Vijver M. J.v.D., He Y. D., Veer L. J.v.t., et al. A gene-expression signature as a predictor of survival in breast cancer. New Engl J Med 2002; 347(25)1999–2009
   PubMed Web of Science ®Google Scholar
• Ma X. J., Wang Z., Ryan P. D., et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 2004; 5: 1–10
   PubMedGoogle Scholar
• Ayers M., Symmans W. F., Stec J., et al. Gene expression profiles predict complete patholo gic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol 2005; 22(12)2284–2293
   Web of Science ®Google Scholar
• Jansen M. P. H. M., Foekens J. A., Staveren I. L.v., et al. Molecular classification of Tamoxifen-resistant breast carcinomas by gene expression profiling. J Clin Oncol 2005; 23(4)732–740
   PubMed Web of Science ®Google Scholar
• Perou C. M., Sorlie T., Eisen M. B., et al. Molecular portraits of human breast tumors. Nature 2000; 406: 747–752
   PubMed Web of Science ®Google Scholar
• Simon R., Radmacher M. D., Dobbin K., McShane L. M. Pitfalls in the analysis of DNA microarray data: class prediction methods. J Natl Cancer Inst 2003; 95: 14–18
   PubMed Web of Science ®Google Scholar
• Benjamini Y., Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc Ser B 1995; 57: 289–300
   Google Scholar
• Tusher V. G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci 2001; 98: 5116–5121
   PubMed Web of Science ®Google Scholar
• Simon R., Lam A. P. BRB-ArrayTools Users Guide (Version 34). Biometric Research Branch National Cancer Institute, Bethesda, MD 2005, http://linus.nci.nih.gov./brb Technical Report 46
   Google Scholar
• Subramanian A., Tamayo P., Mootha V. K. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102(43)15545–15550
   PubMed Web of Science ®Google Scholar
• Tian L., Greenberg S. A., Kong S. W., Altschuler J., Kohane I. S., Park P. J. Discovering statisti cally significant pathways in expression profiling studies. Proc Natl Acad Sci USA 2005; 102(38)13544–13549
   PubMed Web of Science ®Google Scholar
• Radmacher M. D., McShane L. M., Simon R. A paradigm for class prediction using gene expression profiles. J Comput Biol 2002; 9: 505–511
   PubMed Web of Science ®Google Scholar
• Dudoit S., Fridlyand J. Classification in microarray experiments. Statisti cal Analysis of Gene Expression Microarray Data, T Speed. Chapman & Hall/CRC, New York 2003; 93–158
   Google Scholar
• Rosenwald A., Wright G., Chan W. C., et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. New Engl J Med 2002; 346: 1937–1947
   PubMed Web of Science ®Google Scholar
• Michiels S., Koscielny S., Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005; 365: 488–492
   PubMed Web of Science ®Google Scholar
• Molinaro A. M., Simon R., Pfeiffer R. M. Prediction error estimation: a comparison of resampling methods. Bioinformatics 2005; 21(15)3301–3307
   PubMed Web of Science ®Google Scholar
• Simon R. When is a genomic classifier ready for prime time?. Nat Clin Pract Oncol 2004; 1(1)2–3
   PubMedGoogle Scholar
• Simon R. A roadmap for developing and validating therapeutically relevant genomic classifiers. J Clin Oncol 2005; 23: 7332–7341
   PubMed Web of Science ®Google Scholar
• Dobbin K., Beer D. G., Meyerson M., et al. Inter-laboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin Cancer Res 2005; 11: 565–572
   PubMed Web of Science ®Google Scholar
• Paik S., Shak S., Tang G., et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. New Engl J Med 2004; 351: 2817–2826
   PubMed Web of Science ®Google Scholar
• Simon R., Altaian D. G. Statistical aspects of prognostic factor studies in oncology. Br J Cancer 1994; 69: 979–985
   PubMed Web of Science ®Google Scholar
• Bast R. C., Ravdin P., Hayes D. P., et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19: 1865–1878
   PubMed Web of Science ®Google Scholar
• Simon R., Maitournam A. Evaluating the efficiency of targeted designs for randomized clinical trials. Clin Cancer Res 2004; 10: 6759–6763, supplement and correction 2006, 12, 3229
   PubMed Web of Science ®Google Scholar
• Maitournam A., Simon R. On the efficiency of targeted clinical trials. Stat Med 2005; 24: 329–339
   PubMed Web of Science ®Google Scholar
• Simon R., Wang S. J. Use of genomic signatures in therapeutics development. Pharmacogenomics J 2006; 6: 166–173
   PubMed Web of Science ®Google Scholar
• Freidlin B., Simon R. Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients. Clin Cancer Res 2005; 11: 7872–7878
   PubMed Web of Science ®Google Scholar
• Simon R. Guidelines for the design of clinical studies for development and validation of therapeutically relevant biomarkers and biomarker based classification systems. Biomarkers in Breast Cancer: Molecular Diagnostics for Predictingand Monitoring Therapeutic Effect, D P Hayes, G Gasparini. Humana Press, New York 2005; 3–16
   Google Scholar
• Sargent D. J., Conley B. A., Allegra C., Collette L. Clinical trial designs for predictive marker validation in cancer treatment trials. J Clin Oncol 2005; 23(9)2020–2027
   PubMed Web of Science ®Google Scholar
• Pusztai L., Hess K. R. Clinical trial design for microarray predictive marker discovery and assessment. Ann Oncol 2004; 15: 1731–1737
   PubMed Web of Science ®Google Scholar